Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis
This study is currently recruiting participants.
Verified by University of California, San Francisco, May 2008
Sponsored by: University of California, San Francisco
Information provided by: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT00683371
  Purpose

Mucosal biopsies, endoscopically-guided brush samples of mucus, and a saline lavage taken from the maxillary sinuses of ten CRS patients undergoing sinus surgery are analyzed using three microarrays in order to detect bacteria, fungi and viruses. Ten control patients with normal sinuses will have the same samples taken. The hypothesis is that bacterial, fungal, and viral communities present in the maxillary sinus of patients with CRS are significantly different from those patients with healthy sinuses, and that microorganisms identified in patients with or without CRS will differ from previously published data obtained using other techniques.


Condition Intervention
Maxillary Sinusitis
 Procedure: Specimen collection

MedlinePlus related topics: Molds Sinusitis
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Single Blind (Investigator), Parallel Assignment
Official Title: Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • Microbial community profiling using the PhyloChip, MycoChip, and ViroChip will yield vast quantities of data to be reduced in dimensions for interpretation. Pathogens detected in the nasal mucus of patients with CRS will be compared to healthy controls. [ Time Frame: Immediate Preoperative period. ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The presence or absence of a given microorganism will be compared to previously published data obtained using either traditional culture methods or other genomic methods. [ Time Frame: Immediate preoperative period ] [ Designated as safety issue: No ]

Estimated Enrollment: 20
Study Start Date: October 2007
Estimated Study Completion Date: September 2008
Estimated Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Active Comparator
10 patients with chronic rhinosinusitis will have three specimens collected from the maxillary sinus during surgery
Procedure: Specimen collection
10 patients with chronic rhinosinusitis will have three specimens collected from the maxillary sinus during surgery. The sinus mucosa, sinus mucus and a saline lavage will be collected. The three samples will then be analyzed with microarrays looking for bacteria, fungi, and viruses.
2: Placebo Comparator
10 patients without sinus disease will have three specimens collected from the maxillary sinus during surgery.
Procedure: Specimen collection
10 patients without sinus disease will have three specimens collected from the maxillary sinus during surgery. The sinus mucosa, sinus mucus and a saline lavage will be collected. The three samples will then be analyzed with microarrays looking for bacteria, fungi, and viruses.

Detailed Description:

Mucosal biopsies, endoscopically-guided brush samples of mucus, and a saline lavage taken from the maxillary sinuses of ten CRS patients undergoing sinus surgery are analyzed using three microarrays: 16S rRNA PhyloChip (to detect bacteria), MycoChip (to detect fungi) and ViroChip (to detect viruses). Ten control patients with normal sinuses, as assessed by CT scan and a sinusitis-specific survey, will have the same samples taken. The hypothesis is that bacterial, fungal, and viral communities present in the maxillary sinus of patients with CRS are significantly different from those patients with healthy sinuses, and that microorganisms identified in patients with or without CRS will differ from previously published data obtained using other techniques. Comparing diseased and control flora will provide insight into the relative contribution of each pathogen to CRS and may guide the development of future therapies.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria (CRS patients):

  • History of CRS as defined as symptoms (nasal discharge, nasal obstruction, facial pain and/or hyposmia) for >12 weeks despite therapy.
  • Impaired CRS-specific quality of life (SNOT-20 score >1.5).
  • Evidence of sinus disease on a CT scan (Lund MacKay score greater than or equal to 10).
  • Patients with positive skin or RAST testing to an inhalant allergen and/or aspirin hypersensitivity will be included. Evidence of atopy is not required but will be recorded, along with serum IgE levels, when available.

Inclusion Criteria (Control patients):

  • No history of CRS
  • SNOT-20 score <1.0
  • No evidence of sinus disease on preoperative imaging

Exclusion Criteria:

  • Control patients with any evidence of CRS, by history, survey, or imaging criteria would be excluded.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00683371

Contacts
Contact: Wendy Ma 415-353-2870 wma@ohns.ucsf.edu
Contact: Andrew Goldberg, MD, MSCE 415-353-2757 agoldberg@ohns.ucsf.edu

Locations
United States, California
University of California, San Francisco, Dept of Otolaryngology-HNS Recruiting
San Francisco, California, United States, 94143
Contact: Wendy Ma     415-353-2870     wma@ohns.ucsf.edu    
Contact: Andrew Goldberg, MD, MSCE     415-353-2757     agoldberg@ohns.ucsf.edu    
Principal Investigator: Andrew Goldberg, MD, MSCE            
Sponsors and Collaborators
University of California, San Francisco
Investigators
Principal Investigator: Andrew Goldberg, MD, MSCE University of California, San Francisco
  More Information

Responsible Party: University of California, San Francisco, Department of Otolaryngology-HNS ( Andrew N. Goldberg, MD, MSCE )
Study ID Numbers: H43796-31316-01
Study First Received: May 21, 2008
Last Updated: May 22, 2008
ClinicalTrials.gov Identifier: NCT00683371  
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, San Francisco:
Chronic Rhinosinusitis
Sinus Disease
Allergy
Maxillary Sinus
Microarray

Study placed in the following topic categories:
Hypersensitivity
Otorhinolaryngologic Diseases
Respiratory Tract Infections
 Respiratory Tract Diseases
Maxillary Sinusitis
Sinusitis

Additional relevant MeSH terms:
Paranasal Sinus Diseases
Nose Diseases

ClinicalTrials.gov processed this record on January 16, 2009



U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services